KRSNAA DIAGNOSTICS Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KRSNAA DIAGNOSTICS Quarterly Results    (KRSN)

Here are the latest quarterly results of KRSNAA DIAGNOSTICS. For more details, see the KRSNAA DIAGNOSTICS financial fact sheet and KRSNAA DIAGNOSTICS share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

KRSNAA DIAGNOSTICS Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-21
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m1,083 
Other income Rs m32 
Turnover Rs m1,115 
Expenses Rs m763 
Gross profit Rs m319 
Depreciation Rs m103 
Interest Rs m82 
Profit before tax Rs m166 
Tax Rs m41 
Profit after tax Rs m125 
Gross profit margin %29.5 
Effective tax rate %24.6 
Net profit margin %11.6 
Diluted EPS Rs 4.0  
Diluted EPS (TTM) Rs NA  
 Subscriber Feature    
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster

More Hospital & Healthcare Services Company Quarterly Results:   SUN PHARMA  AUROBINDO PHARMA  DIVIS LABORATORIES  CIPLA  ALEMBIC PHARMA  

Compare KRSNAA DIAGNOSTICS With:   SUN PHARMA  AUROBINDO PHARMA  DIVIS LABORATORIES  CIPLA  ALEMBIC PHARMA  



Today's Market

Sensex Snaps 2-Day Losing Streak, Zooms 887 Points, Nifty Settles Above 17,150; Tata Steel, Axis Bank Top Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Views on news

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for (Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

The Biggest Winners and Losers in India's Transition to Electric Vehicles (Profit Hunter)

Nov 26, 2021

How India's EV transition could be a major headwind for the incumbents.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

KRSNAA DIAGNOSTICS SHARE PRICE


Dec 7, 2021 (Close)

TRACK KRSNAA DIAGNOSTICS

  • Track your investment in KRSNAA DIAGNOSTICS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON KRSNAA DIAGNOSTICS

KRSNAA DIAGNOSTICS - NARAYANA HRUDAYALAYA COMPARISON

COMPARE KRSNAA DIAGNOSTICS WITH

MARKET STATS